541 related articles for article (PubMed ID: 15851308)
1. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
[TBL] [Abstract][Full Text] [Related]
2. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
[TBL] [Abstract][Full Text] [Related]
3. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
5. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
[TBL] [Abstract][Full Text] [Related]
6. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?
Tieleman RG; Van Gelder IC; Crijns HJ; De Kam PJ; Van Den Berg MP; Haaksma J; Van Der Woude HJ; Allessie MA
J Am Coll Cardiol; 1998 Jan; 31(1):167-73. PubMed ID: 9426036
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
[TBL] [Abstract][Full Text] [Related]
8. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation.
Climent VE; Marin F; Mainar L; Gomez-Aldaravi R; Martinez JG; Chorro FJ; Roman P; Sogorb F
Pacing Clin Electrophysiol; 2004 Mar; 27(3):368-72. PubMed ID: 15009866
[TBL] [Abstract][Full Text] [Related]
9. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
[TBL] [Abstract][Full Text] [Related]
10. Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
Oto E; Okutucu S; Katircioglu-Öztürk D; Güvenir HA; Karaagaoglu E; Borggrefe M; Breithardt G; Goette A; Ravens U; Steinbeck G; Wegscheider K; Oto A; Kirchhof P
Europace; 2017 Jun; 19(6):921-928. PubMed ID: 27377074
[TBL] [Abstract][Full Text] [Related]
11. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
Schilling RJ
Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
[TBL] [Abstract][Full Text] [Related]
12. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
13. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
De Simone A; De Pasquale M; De Matteis C; Canciello M; Manzo M; Sabino L; Alfano F; Di Mauro M; Campana A; De Fabrizio G; Vitale DF; Turco P; Stabile G
Eur Heart J; 2003 Aug; 24(15):1425-9. PubMed ID: 12909071
[TBL] [Abstract][Full Text] [Related]
14. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
[TBL] [Abstract][Full Text] [Related]
15. Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
Kirchhof P; Andresen D; Bosch R; Borggrefe M; Meinertz T; Parade U; Ravens U; Samol A; Steinbeck G; Treszl A; Wegscheider K; Breithardt G
Lancet; 2012 Jul; 380(9838):238-46. PubMed ID: 22713626
[TBL] [Abstract][Full Text] [Related]
16. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
[TBL] [Abstract][Full Text] [Related]
17. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
Rajagopalan B; Curtis AB
Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.
Frick M; Frykman V; Jensen-Urstad M; Ostergren J; Rosenqvist M
Clin Cardiol; 2001 Mar; 24(3):238-44. PubMed ID: 11288971
[TBL] [Abstract][Full Text] [Related]
19. Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients.
Gwag HB; Chun KJ; Hwang JK; Park SJ; Kim JS; Park KM; On YK
PLoS One; 2018; 13(5):e0197352. PubMed ID: 29787592
[TBL] [Abstract][Full Text] [Related]
20. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
